Relations between long-term glycemic control and postoperative wound and infectious complications after total knee arthroplasty in type 2 diabetics

Clinics in Orthopedic Surgery

Volumn 5, Issue 2, 2013, Pages 118-123

  Han, Hyuk Soo ^a   Kang, Seung Baik ^a  

^a Seoul National University Boramae Hospital   (South Korea)

Author keywords

Early deep infection; Total knee replacements; Type 2 diabetes mellitus; Wound complication

Indexed keywords

CEPHALOSPORIN; COLISTIN; ERYTHROMYCIN; HEMOGLOBIN A1C; INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; AGE DISTRIBUTION; AGED; ANTIBIOTIC BONE CEMENT; BACTERIUM CULTURE; BLISTER; BLOOD TRANSFUSION; BODY MASS; BONE CEMENT DEVICE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DISEASE DURATION; FEMALE; GLYCEMIC CONTROL; HEMATOMA; HEMOGLOBIN BLOOD LEVEL; HUMAN; INCIDENCE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OPERATION DURATION; POSTOPERATIVE PERIOD; RETROSPECTIVE STUDY; REVIEW; SEX DIFFERENCE; SUCTION DRAINAGE; SURGICAL INFECTION; TOTAL KNEE REPLACEMENT;

EARLY DEEP INFECTION; TOTAL KNEE REPLACEMENTS; TYPE 2 DIABETES MELLITUS; WOUND COMPLICATION;

AGED; AGED, 80 AND OVER; ARTHROPLASTY, REPLACEMENT, KNEE; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INCIDENCE; INSULIN; LOGISTIC MODELS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURGICAL WOUND INFECTION;

EID: 84878151833     PISSN: 2005291X     EISSN: 20054408     Source Type: Journal    
DOI: 10.4055/cios.2013.5.2.118     Document Type: Review

References (30)

1. Meding JB, Reddleman K, Keating ME, et al. Total knee replacement in patients with diabetes mellitus. Clin Orthop Relat Res. 2003;(416):208-16.
2. Muller LM, Gorter KJ, Hak E, et al. Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus. Clin Infect Dis. 2005;41(3):281-8.
3. Golden SH, Peart-Vigilance C, Kao WH, Brancati FL. Perioperative glycemic control and the risk of infectious complications in a cohort of adults with diabetes. Diabetes Care. 1999;22(9):1408-14.
4. Latham R, Lancaster AD, Covington JF, Pirolo JS, Thomas CS Jr. The association of diabetes and glucose control with surgical-site infections among cardiothoracic surgery patients. Infect Control Hosp Epidemiol. 2001;22(10):607-12.
5. Brenner RE, Riemenschneider B, Blum W, et al. Defective stimulation of proliferation and collagen biosynthesis of human bone cells by serum from diabetic patients. Acta Endocrinol (Copenh). 1992;127(6):509-14.
6. Robertson HD, Polk HC, Jr. The mechanism of infection in patients with diabetes mellitus: a review of leukocyte malfunction. Surgery. 1974;75(1):123-8.
7. van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med. 2001;345(19):1359-67.
8. McMurry JF Jr. Wound healing with diabetes mellitus: better glucose control for better wound healing in diabetes. Surg Clin North Am. 1984;64(4):769-78.
9. Rohlfing CL, Wiedmeyer HM, Little RR, England JD, Tennill A, Goldstein DE. Defining the relationship between plasma glucose and HbA(1c): analysis of glucose profiles and HbA(1c) in the Diabetes Control and Complications Trial. Diabetes Care. 2002;25(2):275-8.
10. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med. 1993;329(14):977-86.
11. Intensive blood-glucose control with sulphonylureas orinsulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33): UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352(9131):837-53.
12. Sacks DB, Bruns DE, Goldstein DE, Maclaren NK, McDonald JM, Parrott M. Guidelines and recommendationsfor laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem. 2002;48(3):436-72.
13. Jain NB, Guller U, Pietrobon R, Bond TK, Higgins LD. Comorbidities increase complication rates in patients having arthroplasty. Clin Orthop Relat Res. 2005;(435):232-8.
14. McQueen MM, Hughes SP, May P, Verity L. Cefuroxime intotal joint arthroplasty: intravenous or in bone cement. J Arthroplasty. 1990;5(2):169-72.
15. Miner AL, Losina E, Katz JN, Fossel AH, Platt R. Deep infection after total knee replacement: impact of laminar airflow systems and body exhaust suits in the modern operating room. Infect Control Hosp Epidemiol. 2007;28(2):222-6.
16. Wen CP, David Cheng TY, Tsai SP, et al. Are Asians at greater mortality risks for being overweight than Caucasians? Redefining obesity for Asians. Public Health Nutr. 2009;12(4): 497-506.
17. O'Sullivan CJ, Hynes N, Mahendran B, et al. Haemoglobin A1c (HbA1C) in non-diabetic and diabetic vascular patients. Is HbA1C an independent risk factor and predictor of adverse outcome? Eur J Vasc Endovasc Surg. 2006;32(2):188-97.
18. Bishop JR, Moul JW, Sihelnik SA, Peppas DS, Gormley TS, McLeod DG. Use of glycosylated hemoglobin to identify diabetics at high risk for penile periprosthetic infections. J Urol. 1992;147(2):386-8.
19. Lin HT, Tsai CS, Chen YL, Liang JG. Influence of diabetesmellitus on deep neck infection. J Laryngol Otol. 2006;120(8):650-4.
20. Wilson SK, Carson CC, Cleves MA, Delk JR 2nd. Quantifying risk of penile prosthesis infection with elevated glycosylated hemoglobin. J Urol. 1998;159(5):1537-9.
21. Boltz MM, Hollenbeak CS, Julian KG, Ortenzi G, Dillon PW. Hospital costs associated with surgical site infections in general and vascular surgery patients. Surgery. 2011;150(5): 934-42.
22. England SP, Stern SH, Insall JN, Windsor RE. Total knee arthroplasty in diabetes mellitus. Clin Orthop Relat Res. 1990; (260):130-4.
23. Yang K, Yeo SJ, Lee BP, Lo NN. Total knee arthroplasty in diabetic patients: a study of 109 consecutive cases. J Arthroplasty. 2001;16(1):102-6.
24. Babkin Y, Raveh D, Lifschitz M, et al. Incidence and risk factors for surgical infection after total knee replacement. Scand J Infect Dis. 2007;39(10):890-5.
25. Gaine WJ, Ramamohan NA, Hussein NA, Hullin MG, McCreath SW. Wound infection in hip and knee arthroplasty. J Bone Joint Surg Br. 2000;82(4):561-5.
26. Chiu FY, Lin CF, Chen CM, Lo WH, Chaung TY. Cefuroxime-impregnated cement at primary total knee arthroplasty in diabetes mellitus: a prospective, randomised study. J Bone Joint Surg Br. 2001;83(5):691-5.
27. Dronge AS, Perkal MF, Kancir S, Concato J, Aslan M, Rosenthal RA. Long-term glycemic control and postoperative infectious complications. Arch Surg. 2006;141(4):375-80.
28. Furnary AP, Wu Y. Clinical effects of hyperglycemia in the cardiac surgery population: the Portland Diabetic Project. Endocr Pract. 2006;12 Suppl 3:22-6.
29. Pozzilli P, Leslie RD. Infections and diabetes: mechanisms and prospects for prevention. Diabet Med. 1994;11(10):935-41.
30. Tsukayama DT, Goldberg VM, Kyle R. Diagnosis and management of infection after total knee arthroplasty. J Bone Joint Surg Am. 2003;85 Suppl 1:S75-80.